Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck CEO Frazier credits Keytruda success to slim-down strategy
Merck CEO Frazier credits Keytruda success to slim-down strategy
Merck CEO Frazier credits Keytruda success to slim-down strategy
Submitted by
admin
on January 13, 2015 - 10:47am
Source:
Fierce Pharma
News Tags:
Merck
Pharma CEOs
Kenneth Frazier
Keytruda
Yervoy
melanoma
Headline:
Merck CEO Frazier credits Keytruda success to slim-down strategy
Do Not Allow Advertisers to Use My Personal information
